ArticleJournal of clinical laboratory analysis2022

MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.

Xiaoxia Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.